Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RATe control in Atrial Fibrillation II
2015-001918-98Phase 4Completed
- Sponsor
- Vestre Viken Hospital Trust
- Start
- Nov 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial in Atrial fibrillation (AFib) comparing Selo-Zok with Cardizem Uno (2 arms). Primary endpoint: NT-proBNP level. Started Nov 2015; status: completed.
02
Drugs
Cormetdiltiazem
03
Conditions
Atrial fibrillation (AFib)
Beyond the preview
Go deeper on 2015-001918-98.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2015-001918-98.